SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK946.68m
- SEK913.23m
- SEK200.23m
Brief: Sedana Medical Says Received Positive Outcome For European Registration Application For Drug Sedaconda
Brief: Sedana Medical Announces Positive FDA Interaction
Brief: Sedana Medical Gets QMS MDR Approval
Brief: Sedana Medical Appoints Johannes Doll As New CEO
Brief: Sedana Medical Q1 Gross Profit Rises To SEK 29 Mln
Brief: Sedana Medical Q4 EBIT Loss Widens To SEK 7 Mln
Brief: Sedana Medical Says CEO Christer Ahlberg Is Leaving The Company
Brief: Sedana Medical Submits Application For Market Approval For Sedaconda For Inhaled Sedation In Intensive Care In UK
Brief: Sedana Medical Submits Market Approval Application For Drug Sedaconda
Brief: Sedana Medical Receives Additional Patent For Anaconda
Brief: Sedana Medical Q3 EBIT Loss Widens To SEK 11.7 Million
Brief: Sedana Medical's AnaConDa Reviewed By NICE In UK
Brief: Sedana Medical Appoints New CFO
Brief: Sedana Q2 EBITDA Loss Narrows To SEK 0.8 Mln
Brief: Sedana Signs Distribution Deal In Australia And New Zeeland
Brief: Sedana Medical: Positive Top Line Result In Pivotal IsoConDa Study
Brief: Sedana Medical Gets Market Approval In Saudi Arabia And Signs Distribution Deals
Brief: Sedana Medical Signs Distribution Agreements
Brief: Sedana Medical Q1 EBITDA Swings To Profit Of SEK 1.2 Mln